Biosurveillance Monitoring Pilot to Launch at Three U.S. Airports
XpresSpa Group has been authorized to proceed with a $2 million dollar, 8-week pilot program with the Centers for Disease Control and Prevention (CDC) through its XpresCheck COVID-19 testing company. Keep Reading